Table 3.

Summary of adverse events in immune checkpoint inhibition.

Agent	Adverse events
Pembrolizumab	Arthralgia, Pneumonitis, Hepatotoxicity, Autoimmune hepatitis, Fatigue, Pruritus, Rash, Diarrhea, Colitis, Nausea, Vomiting, Hypothyroidism, Hyperthyroidism
Nivolumab	Endocrine toxicities, Pneumonitis, Hepatitis, Diarrhea, Colitis, Fatigue, Pruritus, Nausea
Atezolizumab	Fatigue, Hypothyroidism, Nausea, Vomiting, Pruritus, Rash, Diarrhea, Pneumonitis, Arthralgia
Ipilimumab	Skin, Gastrointestinal toxicities, Renal toxicities, Autoimmune hepatitis, Fatigue, Diarrhea, Colitis, Nausea, Vomiting, Pneumonitis, Hypothyroidism, Hyperthyroidism, Arthralgia

The major adverse events are depicted in boldface.